crispr therapeutics, mgh team up on new cancer treatments.

yet these drugs are not a "home run," says elizabeth loder, md, a professor of neurology at harvard medical school and chief of the division of headache at brigham & women's hospital..

.

"it has been a long two years and throughout that time the western trust has not been assisting us in trying to understand the circumstances around our mother's death.